Trials / Conditions / Recurrent Liver Carcinoma
Recurrent Liver Carcinoma
3 registered clinical trials studyying Recurrent Liver Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642 | Mayo Clinic | — |
| Completed | Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer NCT03008343 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060 | National Cancer Institute (NCI) | Phase 2 |